Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Share-based Compensation (Details Textual)

v3.20.1
Note 10 - Share-based Compensation (Details Textual) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)     800,000 900,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)     $ 190.80 $ 173.89
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)     $ 37.01 $ 34.66
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in shares)     398,320 263,995
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value     $ 48.6 $ 22.3
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total $ 30.1   $ 30.1  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)     2 years  
Selling, General and Administrative Expenses [Member]        
Share-based Payment Arrangement, Expense 7.6 $ 5.7 $ 26.1 $ 24.2
Cost of Sales [Member]        
Share-based Payment Arrangement, Expense $ 0.5   $ 1.4  
Restricted Stock Units (RSUs) [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)     30,858 56,403
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)     $ 192.08 $ 170.96
Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)     15,398 14,887
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)     $ 193.48 $ 177.93